In 2023, Italy led global antidepressant sales among the listed countries, with a significant value of $702.4 million USD, marking a 4.6% increase from the previous year. Chile followed with $250.4 million USD, showing the highest year-on-year growth at 8.97%. Greece and Austria experienced slight declines, while Finland and Estonia saw notable increases of 5.94% and 6.78%, respectively. Luxumbourg registered the largest decrease at 2.87%. Over a five-year period, the compound annual growth rate (CAGR) indicates overall growth, although specific rates vary by country.
Future trends to monitor include:
- The impact of evolving mental health awareness and healthcare policies on sales dynamics.
- Potential economic fluctuations affecting procurement and affordability of antidepressants.
- Advancements in pharmaceuticals and alternative therapies influencing market demands.
Top countries in Antidepressant Medicine Sales by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 702.4 | 2023 | +4.93% | +4.6% | View data |
| 2 | 2 Chile | 250.4 | 2023 | +5.03% | +8.97% | View data |
| 3 | 3 Greece | 176.4 | 2023 | -0.68% | -1.27% | View data |
| 4 | 4 Belgium | 167.6 | 2023 | -1.99% | +1.41% | View data |
| 5 | 5 Czech Republic | 131.9 | 2023 | +1.77% | +2.43% | View data |
| 6 | 6 Austria | 96.5 | 2023 | -1.13% | -0.89% | View data |
| 7 | 7 Sweden | 85.7 | 2023 | -1.38% | +0.96% | View data |
| 8 | 8 Finland | 49.1 | 2023 | +2.72% | +5.94% | View data |
| 9 | 9 Slovakia | 32.1 | 2023 | 0% | +0.7% | View data |
| 10 | 10 Slovenia | 21.8 | 2023 | -0.46% | +2.25% | View data |
